| Not Yet Recruiting | Fatty Liver and Pancreatic Steatosis NCT06757348 | Maria Marta Piskorz | — |
| Recruiting | Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly NCT07068191 | Phenomen Pharma | N/A |
| Recruiting | Lifestyle Changes in Fatty Liver; Additive Effect of Honey Intake NCT06596109 | Cairo University | N/A |
| Active Not Recruiting | Nutritional Education Program for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) NCT06503120 | Taichung Veterans General Hospital | N/A |
| Completed | Probiotic Supplement Versus Placebo for the Treatment of Patients With Non-alcoholic Fatty Liver Disease NCT06491342 | Phramongkutklao College of Medicine and Hospital | N/A |
| Completed | Feasibility of Immersive Virtual Reality Dietician Program in Metabolic-dysfunction Associated Steatotic Liver NCT06215131 | Milton S. Hershey Medical Center | N/A |
| Active Not Recruiting | Development of a Novel Asian Mediterranean Diet and Its Acceptability in NAFLD NCT06321211 | Singapore Institute of Technology | — |
| Unknown | Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines NCT06257732 | Yeditepe University | N/A |
| Completed | The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Di NCT06117137 | Sohag University | Phase 3 |
| Recruiting | Prevalence of NAFLD in T1DM Patients NCT06445361 | Ziekenhuis Oost-Limburg | N/A |
| Completed | A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6 NCT05877547 | Merck Sharp & Dohme LLC | Phase 2 |
| Active Not Recruiting | Quantification of Hepatic Steatosis With Different Ultrasound Frequency NCT05855239 | Jong Keon Jang | — |
| Completed | Evaluation of the Effects of Orange Consumption on Carbohydrate and Lipid Metabolism in Subjects With MAFLD (M NCT05558592 | Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | N/A |
| Withdrawn | Effects of Mindfulness Based Stress Reduction Intervention in Patients With Non-alcoholic Fatty Liver Disease NCT05130346 | Virginia Commonwealth University | N/A |
| Completed | Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Live NCT05560607 | AstraZeneca | Phase 1 |
| Recruiting | Intermittent Fasting for NAFLD in Adults NCT04899102 | Massachusetts General Hospital | N/A |
| Unknown | Impact of Time-restricted Feeding in NAFLD NCT05220956 | Johannes Gutenberg University Mainz | N/A |
| Unknown | Anti-diabetic Drugs and Fatty Liver Management NCT05041673 | Alexandria University | N/A |
| Withdrawn | Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease NCT04761848 | Sadat City University | Phase 1 / Phase 2 |
| Unknown | Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH NCT04702490 | Metacrine, Inc. | Phase 2 |
| Completed | Quantitative US for Evaluation of Hepatic Steatosis in NAFLD NCT04462562 | Seoul National University Hospital | N/A |
| Completed | Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Elect NCT04241575 | Chinese University of Hong Kong | N/A |
| Completed | Enhanced Liver Function in Non-alcoholic Obese Fatty Liver Patients by Low Level Laser Therapy NCT04452409 | Cairo University | N/A |
| Completed | Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool NCT04067440 | Universität des Saarlandes | — |
| Completed | Glycemic Index/Saturated Fatty Acid Diet and Hepatic Fat NCT04054297 | Maastricht University Medical Center | N/A |
| Completed | Ketogenic Diet in Non-alcoholic Fatty Liver Disease NCT03784716 | Marc Goodman | N/A |
| Active Not Recruiting | Prevalence of NAFLD in T2DM Patients NCT06445335 | Ziekenhuis Oost-Limburg | N/A |
| Completed | Hepatic Glycogen and Fat Oxidation NCT03593343 | Maastricht University Medical Center | N/A |
| Completed | A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) NCT03656744 | HighTide Biopharma Pty Ltd | Phase 2 |
| Completed | The Effects of a Novel Lifestyle Intervention Program on Insulin Sensitivity in Type 2 Diabetes NCT04509245 | German Diabetes Center | N/A |
| Completed | Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fat NCT03371355 | Akcea Therapeutics | Phase 2 |
| Completed | The Effect of Combination Therapy Amino Acid L-CARNITINE and Magnesium on Fatty Liver NCT03319199 | Rawi Hazzan | N/A |
| Completed | Determinants of Liver Fat Composition NCT03211299 | Maastricht University Medical Center | — |
| Completed | The Effects of Zataria Multiflora Boiss (Shirazi's Thyme) on Nonalcoholic Fatty Liver Disease NCT02983669 | Shiraz University of Medical Sciences | N/A |
| Unknown | Mechanism of Serum PRL in the Development of MAFLD NCT05525884 | Shen Qu | — |
| Completed | Efficacy and Safety of Fermented Ginseng Powder on Liver Function NCT03260543 | Chonbuk National University Hospital | N/A |
| Completed | Effects of Pitavastatin on Insulin Sensitivity and Liver Fat NCT02290106 | Massachusetts General Hospital | N/A |
| Completed | Nutritional Counseling vs. Nutritional Supplements for NASH - a Randomized Prospective, Open Label Pilot Study NCT02366052 | Johannes Gutenberg University Mainz | Phase 2 |
| Unknown | Probiotics in the Treatment of NAFLD NCT02764047 | Federal University of Health Science of Porto Alegre | N/A |
| Completed | Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease NCT02132780 | Virginia Commonwealth University | — |